[1]
Z. Aslam, M. Mumtaz, and N. Malkani, “Evaluation of Serum Circulating Levels of ICAM-1 as Tuberculosis Risk-assessment Factor in Type 2 Diabetes Patients”, PRHSJ, vol. 38, no. 1, pp. 22–26, Mar. 2019.